BioSpring GmbH

Will you be at this year’s NatsJ conference in Sendai? Head of Manufacturing Site I Patrick Seyfried will be presenting on BioSpring’s innovations in oligonucleotide manufacturing sustainability solutions. Make sure to check out his presentation on July 14, 5PM JST. #Sustainability #Oligonucleotides #BioSpring #NatsJ

Welcome to part two of our mRNA knowledge series. Do you know how mRNA is produced enzymatically? No worries, we got you covered. #BioSpring #mRNA

We‘re dedicating the month of July to mRNA! Let‘s explore the incredible science behind mRNA together. Stay tuned to learn more on mRNA, enzymatic manufacturing and its applications. #BioSpring #mRNA

Do you know how the body makes proteins? According to these elementary school students, it might be a bit more colorful than you expect! As part of BioSpring’s afterschool program with the Freiligrath School, students were able to learn about how mRNA works with ribosomes and tRNA to produce proteins, all while producing these works of art. #mRNA #Science #STEM #YoungScientists #BioSpring

Ciao! It’s our last day at IOPC in Milan, so remember to visit Table 21 to connect with the BioSpring team on your next nucleic acid program. Before we go, a quick hint on our next stop: 🌸🎋 #IOPC #IOPC2024 #BioSpring #Oligonucleotides #Manufacturing

We are proud to announce that as of today, BioSpring’s CEO Dr. Sylvia Wojczewski, has been elected into the presidential board of the “Federation of German Industries” (Bundesverband der Deutschen Industrie (BDI)) for the remainder of the 2023/2024 term. The BDI is the umbrella organization of the German industries and industry-related service providers. One of its members is BioDeutschland, the German biotech organization where Dr. Sylvia Wojczewski has served as a member of the executive board since 2013. It will be the first time that a member of BioDeutschland has been elected into the highest governing body of the BDI. Dr. Sylvia Wojczewski is delighted about this new opportunity:  “I am honored to contribute my experience within the biotech industry to the BDI.” #BioSpring #BDI # BundesverbandDerDeutschenIndustrie #BioDeutschland

Announcing our next exhibit at the 5th IOPC in Milan, Italy, starting on June 25! This event marks the next stop on our global conference tour. We're racking up frequent flyer miles as we bring our nucleic acid expertise around the world. ✈️ If you have a nucleic acid program or would like to learn more about our comprehensive manufacturing and analytical services, please visit Table 21, before we take off to our next destination! #IOPC2024 #Oligonucleotides #Milan

There are many reasons why we are the world-leading guide RNA manufacturer. BioSpring expertly manufactures and analyzes custom GMP guide RNA for your genome editing programs. Learn more about our comprehensive services here: https://lnkd.in/g8VEgS6R #GuideRNA #GenomeEditing #BioSpring

We are excited to announce that on June 12, 2024, the "National Strategy for Gene and Cell-Based Therapies" was presented to Federal Research Minister Bettina Stark-Watzinger (FDP). This marks a major step forward for future technologies and value creation in Germany! BioSpring contributed expertise in promoting GMP production, simplifying regulatory requirements, and strengthening talent and education. The strategy aims to improve the translation of research findings into healthcare, addressing challenges in clinical trial approvals and new therapeutics like CRISPR/Cas and CAR-T cell treatments. We are proud to be part of this initiative, shaping the future of gene and cell-based therapies in Germany. Here is the link to the press release and the strategy paper: https://lnkd.in/esb3DQ_X  https://lnkd.in/dn5U_5TW  #HealthcareInnovation #BioSpring #GeneTherapy #CellTherapy #ResearchAndDevelopment #Germany #NationalStrategy #GCTGermany  #NationaleStrategieGCT  

BioSpring's QC researchers, Dr. Michael Rühl and Dr. Christopher Gawlig, each presented posters at the American Society For Mass Spectrometry (ASMS) conference last week. Additionally, they presented collaboratively with Waters Corporation at the Waters User Meeting. Internal research is a key initiative at BioSpring, driving continuous advancements crucial for the future of therapeutic development. We are dedicated to improving nucleic acid quantification methods and exploring opportunities to enhance quality, ensuring we always manufacture at the highest standard. #ASMS #BioSpring #Oligonucleotides #QualityControl